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The role of GluN2A and GluN2B NMDA receptor
subunits in AgRP and POMC neurons on body
weight and glucose homeostasis
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ABSTRACT
Objective: Hypothalamic agouti-related peptide (AgRP) and pro-opiomelanocortin (POMC) expressing neurons play critical roles in control of
energy balance. Glutamatergic input via n-methyl-D-aspartate receptors (NMDARs) is pivotal for regulation of neuronal activity and is required in
AgRP neurons for normal body weight homeostasis. NMDARs typically consist of the obligatory GluN1 subunit and different GluN2 subunits, the
latter exerting crucial differential effects on channel activity and neuronal function. Currently, the role of speciﬁc GluN2 subunits in AgRP and
POMC neurons on whole body energy and glucose balance is unknown.
Methods: We used the cre-lox system to genetically delete GluN2A or GluN2B only from AgRP or POMC neurons in mice. Mice were then
subjected to metabolic analyses and assessment of AgRP and POMC neuronal function through morphological studies.
Results: We show that loss of GluN2B from AgRP neurons reduces body weight, fat mass, and food intake, whereas GluN2B in POMC neurons is
not required for normal energy balance control. GluN2A subunits in either AgRP or POMC neurons are not required for regulation of body weight.
Deletion of GluN2B reduces the number of AgRP neurons and decreases their dendritic length. In addition, loss of GluN2B in AgRP neurons of the
morbidly obese and severely diabetic leptin-deﬁcient Lepob/ob mice does not affect body weight and food intake but, remarkably, leads to full
correction of hyperglycemia. Lepob/ob mice lacking GluN2B in AgRP neurons are also more sensitive to leptin’s anti-obesity actions.
Conclusions: GluN2B-containing NMDA receptors in AgRP neurons play a critical role in central control of body weight homeostasis and blood
glucose balance via mechanisms that likely involve regulation of AgRP neuronal survival and structure, and modulation of hypothalamic leptin action.
 2015 The Authors. Published by Elsevier GmbH. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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1. INTRODUCTION
Hypothalamic agouti related peptide (AgRP) and proopiomelanocortin
(POMC) producing neurons play important roles in the regulation of
body weight homeostasis. Activation of AgRP neurons in mice pro-
motes a state of positive energy balance by increasing energy intake
and decreasing energy expenditure, while stimulation of POMC neu-
rons promote a state of negative energy balance [1e6]. Arcuate nu-
cleus (ARC) AgRP and POMC neurons are regulated by neuronal
synaptic inputs, circulating metabolites and peripheral hormonal sig-
nals such as leptin, insulin and ghrelin. Both groups of cells also have
the capacity to mediate potent anti-diabetic actions by leptin [7e9].
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Although signiﬁcant progress has been made in understanding the
action of these hormonal signals in control of AgRP and POMC neurons
on energy balance regulation [10e12], little is known about the roles
of upstream neural inputs such as glutamate, gamma-aminobutyric
acid (GABA) and serotonin [13e16].
N-methyl-D-aspartate receptors (NMDARs) are ligand-gated ion (Ca2þ)
channels activated by the neurotransmitter glutamate and are amongst
the most important proteins in the post-synaptic density of excitatory
synapses [17,18]. The NMDAR is a heteromeric channel comprised of
two obligatory GluN1 (NR1) subunits together with two GluN2 subunits
(GluN2A, 2B, 2C, or 2D) (NR2A-D), and/or GluN3 subunits (NR3A and
NR3B). Most native NMDARs appear to function as assemblies
composed of two GluN1 subunits and two GluN2 subunits, typically
GluN2A and GluN2B [17,19]. The identity of the GluN2 subunits is critical
for the biophysical and pharmacological properties of the receptor and
for the regulation of neuronal processes. For example, GluN2B-
containing NMDARs have longer decay times compared with GluN2A,
thus integrating excitatory post-synaptic synaptic currents (EPSCs)
across broader time intervals [20]. Also, GluN2A and GluN2B containing
channels differentially control synaptic activity via distinct effects on
translocation of a-amino-3-hydroxy-5-methyl-4-isoxazolepropionic
acid receptors (AMPARs) to the post synaptic membrane [21]. Genetic
loss of GluN2B in mice causes defective synaptic development and early
postnatal death [22e24] while global deletion of GluN2A allows survival
but causes impaired spatial learning [25].
Hypothalamic NMDARs can inﬂuence energy balance acutely as
intrahypothalamic injection of glutamate analogs (NMDAR-speciﬁc)
elicits robust eating behavior [26] whereas NMDAR-speciﬁc antago-
nists suppress feeding [27,28]. In addition, genetic deletion of the
obligatory GluN1 subunit only from AgRP neurons reduces body weight
and food intake [14]. Moreover, an excitatory paraventricular hypo-
thalamic nucleus (PVN) to AgRP neuronal circuit that drives hunger has
recently been described, further underscoring the importance of glu-
tamatergic input to speciﬁc arcuate hypothalamic neurons in control of
energy balance regulation [29]. While these data show that hypotha-
lamic glutamatergic action and NMDARs are important for energy
balance control in a neuron speciﬁc manner, the contributions of in-
dividual GluN2 subunits, speciﬁcally GluN2A and GluN2B, within the
key AgRP and POMC neurons are unknown.
NMDARs mediate acute excitatory neurotransmission [30e32]. In the
longer term, NMDARs also serve to regulate dendritic growth, arbori-
zation and spine density, thus inﬂuencing neuronal function and
connectivity as well as neuronal development and cell survival
[25,33e35]. In the hippocampus, these cellular events greatly depend
on speciﬁc GluN2 subunits and underlie important processes such
long-term potentiation and depression (LTP and LTD), which likely
controls cognitive functions such as learning and memory [25,36]. In
AgRP neurons, NMDARs regulate spine density and are required for
normal responses to fasting [14]. Neuronal plasticity of POMC and
AgRP neurons may also be critical for the regulation of energy ho-
meostasis by the fat-derived hormone leptin [37,38].
Investigation of NMDARs and speciﬁc GluN2 subunits within critical
hypothalamic neurons is therefore important for our full understanding
of normal energy balance regulation and has the potential for gaining
insights into novel anti-obesity drug targets.
2. MATERIALS AND METHODS
2.1. Animal studies and metabolic parameters
All studies were approved by the Beth Israel Deaconess Medical Center
Institutional Animal Care and Use Committee and conducted in
accordance with federal laws and guidelines. Unless otherwise
speciﬁed, mice 3e19 weeks of age were used and single-housed at
22e24 C using a 12 h light/12 h dark cycle with ad libitum access to
standard mouse chow (LabDiet) and water. Body weight, food intake
and body composition measurements, determination of blood
composition including ELISA assays, and leptin sensitivity (500 ng/h for
13 days), glucose and insulin tolerance test (GTT/ITT) and pair-feeding
were performed as we have described earlier [7,8].
2.2. High-fat diet
At 4 weeks of age, groups of mice were subjected to high-fat diet
(Research Diets) consisting of 60% fat by energy (kcal). Control mice
were fed a low-fat diet (16.7% fat by energy [kcal], (standard chow)).
2.3. Deletion of GluN2A and GluN2B in AgRP and POMC neurons
We used the cre-lox system to delete GluN2A or GluN2B subunits of
NMDARs in AgRP or POMC neurons. AgRP-ires-cre and POMC-cre
mice were generated as described earlier [39e41]. GluN2Aﬂox/ﬂox and
GluN2Bﬂox/ﬂox mice were obtained from Drs. Nicoll and Sakimura [21],
and Dr. Delpire [33], respectively. GluN2Aﬂox/ﬂox (or GluN2Bﬂox/ﬂox) mice
were crossed with AgRP-ires-cre (or POMC-cre) mice in order to
generate GluN2A(or 2B)ﬂox/ﬂox;AgRP-ires-cre (or POMC-cre) mice.
Control GluN2A(or 2B)ﬂox/ﬂox mice and GluN2A(or 2B)ﬂox/ﬂox;AgRP-ires-
cre (or POMC-cre) study mice were obtained by mating GluN2A(or
2B)ﬂox/ﬂox mice with GluN2A(or 2B)ﬂox/ﬂox;AgRP-ires-cre (or POMC-cre)
mice. All studies were performed on age- and sex-matched littermates
from these breedings.
2.4. Hypothalamic AgRP and POMC neuronal counting
Control and AgRP-GluN2B KO mice expressing human renilla (hr)GFP in
AgRP neurons were generated by crossing GluN2Bﬂox/ﬂox, AgRP-ires-
cre and NPY-hrGFP mice [42]. Similarly, control and POMC-GluN2B KO
mice expressing hrGFP in POMC neurons were generated by crossing
GluN2Bﬂox/ﬂox, POMC-cre and POMC-hrGFP mice [43].
Male mice at 8 weeks of age were deeply anesthetized with ketamin
(40 mg/kg) and xylazine (10 mg/kg) and brains were ﬁxated with
formalin through transcardiac perfusion. Coronal brain sections were
generated (4 series, 30 mm thickness) as described earlier [7,8]. To
quantify the number of hypothalamic AgRP and POMC neuronal cell
bodies, brain sections were immunostained for hrGFP as we have
generally described earlier [8,44]. Brieﬂy, one of the four series was
incubated with hrGFP antibodies (Agilent Technologies) (1:2000). After
washing, the slices were incubated with secondary antibodies
(donkey-anti-rabbit), developed with a 3-30-Diaminobenzidine (DAB)
mixture (Vector Laboratories), and ﬁnally mounted onto superfrost plus
microscope slides (VWR Scientiﬁc). The number of neurons in the
arcuate hypothalamic nucleus was counted manually in all sections
with positive cells (8e10 sections/series) under a light microscope
(Olympus (40 or 100 objective and 10 ocular)). The combined
cell count from all sections and both hemispheres were ﬁnally multi-
plied with four (1:4 series) to estimate the total number of hrGFP
positive cells in the brain.
2.5. Dendritic morphology
Cre-Dependent rAAV8/hSyn-DIO-mCherry (3.8  10e12 virus mole-
cules/mL) kindly provided from Dr. Bryan Roth of the University of North
Carolina Vector Core was diluted 1:100 with PBS and injected bilat-
erally (100 nL each) into the arcuate nucleus (coordinates, bregma:
anterior-posterior, 1.40 mm; dorsal-ventral, 5.75 mm; lateral,
0.30 mm) of 5 weeks old GluN2Bﬂox/ﬂox;AgRP-ires-cre or AgRP-ires-
cre (control) mice by using a stereotaxic system from KOPF
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instruments. This low concentration of virus was selected after testing
several dilutions such that a total of only 5e10 neurons were
expressing mCherry in the entire hypothalamus. This very low number
of ﬂuorescent neurons allowed for clear identiﬁcation and analyses of
individual soma and their associated ﬁbers. After 3 weeks, animals
were perfused as described above and brains cut in 150 mm thick
coronal sections. Sections were washed three times, 10 min/each in
PBS, pH 7.4, and permeabilized with 1  PBS/0.4% Triton x100
(Fisher Biotech) for 1 h at room temperature (RT). A buffer with 1%
bovine serum albumin (SigmaeAldrich, Inc) and 3% normal donkey
serum (Jackson ImmunoResearch Laboratories) in 1  PBS/0.4%
Triton 100 was used to block the tissue for 1 h at RT. Sections were
then incubated overnight with rabbit anti-DsRed primary antibody
(Clonetech; 1:1000) in the blocking buffer. Next day, sections were
washed with 1 PBS/0.4% Triton100 three times, 10 min each and
incubated for 2 h at RT with Alexa-594-anti-rabbit secondary antibody
(Invitrogen; 1:500). Finally, the tissue was washed again in 1  PBS/
0.4% Triton x100 three times and mounted on slides with mounting
medium (Vector Laboratories, Inc). A Carl Zeiss confocal microscope
(Objective Plan-Apochromat 20/0.8) was used to take serial Z-stacks
of primary dendrites labeled with mCherry, and a 3D projection was
generated with the LSM (Zeiss) software. The ImageJ software (NIH, v.
1.48s) was subsequently applied to measure dendritic lengths. The
selection of neurons and their associated dendritic ﬁbers for analyses
were done as follows: 1) only somata located within the hypothalamic
arcuate nucleus were selected for further analyses; 2) only ﬁbers that
were associated with identiﬁable arcuate somata were selected; 3)
axonal ﬁbers were excluded based on their small diameter relative to
dendrites and/or presence of boutons: 4) only primary dendrites longer
than 50 mm were measured (from soma to longest terminus); 5)
dendrites that appeared to extend out of the brain section (severed
during sectioning) were excluded from the study. AgRP neurons typi-
cally had 1e3 primary dendrites and few, if any branches.
2.6. Statistical analysis
All values are presented as means  SEM. Repeated measures
including body weight and food intake in normal-, pair- and high-fat diet,
GTT and ITT, leptin sensitivity were tested by using repeated-measures
2-way analysis of variance (ANOVA) or analysis of covariance (ANCOVA)
with Tukey HSD post hoc test for multiple comparisons and Student’s t
test or ManneWhitney U test was done when comparing only two
groups. ANCOVA was conducted for GTT and ITT, levels of glucose and
insulin, and leptin sensitivity. For this purpose, body weight values were
used as covariate even though body weight-matched values were ob-
tained [45]. Post hoc analysis was performed when group differences
and/or group-by-time interaction are signiﬁcant by repeated-measures
two-way ANOVA or ANCOVA. Logarithmic transformation was used for
some data that have variances not homogeneous. P  0.05 were
considered signiﬁcant for all independent factors.
3. RESULTS
3.1. Deletion of GluN2B in AgRP, but not in POMC neurons causes
decreased body weight, caloric intake, fat mass, and circulating
leptin levels
Intrahypothalamic injection of NMDAR/GluN2B agonists or antagonists
elicits rapid feeding responses [26e28]. Furthermore, GluN1 deletion
from AgRP neurons causes reductions in body weight, food intake, and
body fat mass in mice [14]. Yet the role of speciﬁc GluN2 subunits within
key hypothalamic neuronal groups remains unknown. We here exam-
ined whether GluN2A and GluN2B subunits in AgRP and POMC neurons
are important for energy homeostasis control. We observed that mice
lacking GluN2B in AgRP neurons had reduced body weight (Figure 1A
and B), and cumulative food intake (Figure 1C and D) in male and female
mice. Fat mass (Figure 1E) and blood leptin levels (Figure 1F) were also
decreased in female mice. Male AgRP-GluN2B KO mice also exhibited
lower fat mass relative to controls (2.75  0.68 g; 4.66  0.61 g;
P ¼ 0.07), although not quiet reaching statistical signiﬁcance. In
contrast, GluN2B deletion in POMC neurons did not affect body weight,
food intake, body composition or leptin levels (Figure 2AeD). These
results suggest that NMDAR GluN2B subunits in AgRP neurons are
required for normal regulation of body weight homeostasis. In contrast,
GluN2A neuron speciﬁc deletion from AgRP or POMC neurons did not
affect body weight and food intake (Figure 3AeD). We therefore did not
proceed with further studies of mice lacking GluN2A.
3.2. Pair-feeding and high-fat diet
Because GluN2Bﬂox/ﬂox;AgRP-ires-cre mice were lean, we performed a
pair-feeding study to determine whether this lower body weight was
caused by reduced caloric intake or if increased energy expendituremight
also be involved. Pair-feeding of control animals to the average intake
level of GluN2Bﬂox/ﬂox;AgRP-ires-cremice resulted in equal body weights
between the two groups (Figure 4A), demonstrating that the reduced
body weight of KOmice compared to ad lib fed controls (Figure 1A and B)
is likely caused entirely by the reduction in caloric intake [45].
Diet-induced obesity (DIO) is characterized by hyperleptinemia,
resistance to the anorexigenic effects of exogenous leptin, and by
impaired leptin-receptor signaling within hypothalamic POMC and
AgRP neurons [9]. In addition, AgRP neurons of DIO mice exhibit
persistent activation and failure of leptin to reduce ﬁring rates [46].
Since NMDARs regulate neuronal activity, we challenged wild type and
KO mice with a high-fat diet (HFD) to investigate whether GluN2B in
AgRP (and POMC) neurons inﬂuences sensitivity to develop DIO.
Interestingly, the body weights and food intake of GluN2Bﬂox/ﬂox;AgRP-
ires-cre mice on the HFD did not differ when compared to those of
controls (Figure 4B), thus contrasting the lean and hypophagic
phenotype of GluN2Bﬂox/ﬂox;AgRP-ires-cre mice relative to controls
when fed the chow diet (Figure 1). Therefore, when exposed to HFDs,
AgRP-GluN2B KO mice appear more susceptible to weight gain relative
to control animals, if their lower base line body weight on chow diet is
taken into consideration.
3.3. Deletion of GluN2B in AgRP and POMC neurons does not affect
blood glucose, insulin levels, glucose tolerance and insulin tolerance
Because AgRP and POMC neurons can respond to glucose and
orchestrate blood glucose control [7,13,43,47], we measured fed
glucose levels and performed glucose (GTT) and insulin (ITT) tolerance
tests in young body-weight matched mice. GluN2B deletion in AgRP and
POMC neurons did not affect fed blood glucose or serum insulin levels
(Figure 5AeD), GTTs (AUC [AgRP]: 20.2  0.76  103 and
24.1 1.48 103 AgRP-GluN2B KO vs control, P> 0.05. AUC [POMC]:
31.6  2.63  103 and 30.5  1.40  103 POMC-GluN2B KO vs
control, P > 0.05) (Figure 5E and F) or ITTs (AAC [AgRP]:
9.19 0.97 103 and 9.12 0.71 103 AgRP-GluN2B KO vs control,
P > 0.05. AAC [POMC]: 7.46  0.84  103 and 10.8  1.60  103
POMC-GluN2B KO vs control, P > 0.05) (Figure 5G and H).
3.4. Elimination of GluN2B in AgRP neurons of diabetic and obese
Lepob/ob mice normalizes hyperglycemia and increases leptin
sensitivity
We have reported earlier that exogenous leptin can normalize hyper-
glycemia in diabetic, obese and leptin-deﬁcient Lepob/ob mice (ob/ob)
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independently of changes in body weight and caloric intake [7]. This
effect of leptin required presence of leptin receptors in AgRP neurons
and an intact central melanocortin receptor system. Since NMDARs
affect neuronal polarization and activity, we generated ob/ob mice
lacking GluN2B subunits in AgRP neurons (ob/ob;AgRP-GluN2B KO)
and examined body weight and glucose balance, and tested leptin
sensitivity. We found that loss of GluN2B in ob/ob mice did not affect
body weight, body composition and food intake (Figure 6AeC),
Figure 1: GluN2B in AgRP neurons is required for normal body weight and food intake. (AeD) Body weight (males (A) and females (B)) and cumulative food intake (weeks
3e15) (males (C) and females (D)) of control mice (GluN2Bﬂox/ﬂox) and AgRP-GluN2B KO mice. (E and F) Body composition (16 weeks of age) (E) and blood leptin levels (F) of control
(GluN2Bﬂox/ﬂox) and AgRP-GluN2B KO female mice. Data are shown as means  SEM (n ¼ 4e11/group). P values in the line graphs are expressed as differences between groups
(Student’s t test) at the end of the study (week 16). Repeated measures two-way ANOVA and post hoc Tukey HSD tests were conducted to evaluate effect of GluN2B deletion from
AgRP neurons on body weight. Post hoc multiple comparisons were performed using Tukey HSD test. Cumulative food intake and body composition at week 15 and leptin levels at
week 17 were evaluated with Student’s t test. *P  0.05, **P  0.01, ***P  0.001.
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contrasting the lean phenotype of non-ob/ob mice lacking GluN2B in
AgRP neurons (Figure 1). Of additional interest, deletion of GluN2B
from AgRP neurons in the diabetic ob/ob mice entirely normalized
hyperglycemia (Figure 6D). Moreover, in response to exogenous leptin
infusion over a 9-day period, ob/ob mice lacking GluN2B subunits in
AgRP neurons lost more body weight and exhibited a further reduced
food intake relative to ob/ob control animals (Figure 6E and F). Com-
bined, these results show that impaired signaling through GluN2B-
NMDARs in AgRP neurons of diabetic and obese mice causes a ma-
jor improvement in blood glucose control and increases sensitivity to
leptin’s anti-obesity actions.
3.5. Deletion of GluN2B from AgRP neurons reduces neuronal cell
number and alters dendritic morphology
NMDARs play a key role in neuron survival, neuronal plasticity and
dendritic development, and even short-term blockade of NMDARs can
trigger rapid neurodegeneration in the brain [35]. Therefore, since mice
lacking GluN2B subunits in AgRP neurons have altered feeding
behavior, we examined the number of AgRP neurons and assessed
dendritic morphology in AgRP-GluN2B KO mice. To avoid potential
indirect effects due to differences in body weight, body weight-
matched KO and control mice were pre-selected for these studies
(Figure 7E and F). We found that loss of GluN2B subunits from AgRP
neurons caused a marked decrease (w35%) in the number of AgRP
neurons (Figure 7A and C). In contrast, deletion of GluN2B from POMC
neurons did not affect hypothalamic POMC cell numbers (Figure 7B
and D). In addition, GluN2B deletion from AgRP neurons resulted in a
decrease (w40%) in AgRP dendritic length (Figure 8A and B), also
independently of body weight (Figure 8C). These data suggest that
GluN2B NMDARs in hypothalamic AgRP neurons inﬂuence cell number
and dendritic morphology. Therefore, the reduced body weight and
energy intake of mice lacking GluN2B in AgRP neurons may be caused,
at least in part by reduced neuronal survival and/or by altered dendritic
morphology.
4. DISCUSSION
The principal ﬁnding from these studies is that the NMDA receptor
subunit GluN2B in hypothalamic AgRP neurons, but not POMC neurons,
is required for normal body weight homeostasis in mice. In addition,
Figure 2: GluN2B in POMC neurons is not required for normal regulation of body weight and food intake. (A and B) Body weight (A) and cumulative food intake (weeks 3e
15) (B) of control (GluN2Bﬂox/ﬂox) and POMC-GluN2B KO female mice. (C and D) Body composition (15 weeks of age) (C) and blood leptin levels (D) of control (GluN2Bﬂox/ﬂox) and
POMC-GluN2B KO female mice. Data are shown as means  SEM (n ¼ 6e9/group). NS: Not signiﬁcant.
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loss of glutamatergic input via GluN2B-containing NMDARs expressed
on AgRP neurons entirely prevents development of diabetes in obese
leptin-deﬁcient animals. Finally, NR2B-NMDARs control survival and
dendritic morphology of AgRP neurons. These data may be relevant for
future development of novel treatment therapies for human diabetes
and obesity.
Hypothalamic AgRP and POMC neurons serve important functions in
the regulation of energy balance through integration of metabolic,
hormonal and neuronal inputs [1,7,13,43,47]. While signiﬁcant prog-
ress has been made in our understanding of hormonal actions via
these neurons, little is known about the importance of synaptic input by
various neurotransmitters and action via their cognitive post-synaptic
receptors. We here explored the roles of GluN2A and GluN2B, the
two principal NMDAR glutamate-binding subunits [17], in AgRP or
POMC neurons on metabolic and neuronal parameters in mice. Our
results show that GluN2B in AgRP neurons is required for normal body
weight homeostasis. In contrast, mice with loss of GluN2B expression
in POMC neurons exhibit no body weight- or feeding intake-phenotype.
We also show that genetic deletion of GluN2A in AgRP and POMC
neurons does not affect these metabolic parameters. The GluN2B
results are similar to data obtained from studies of mice with AgRP-
speciﬁc deletion of the obligatory GluN1 NMDA receptor subunit
[14]. These studies combined suggest that the principal functional
NMDAR subunit-conﬁguration expressed in hypothalamic AgRP neu-
rons is GluN1/GluN2B.
It is unclear why deletion of GluN2B or GluN2A from POMC neurons
does not inﬂuence body weight or feeding behavior. Clearly POMC
neurons do express functional NMDARs as genetic deletion of GluN1
results in a complete loss of NMDAR-dependent EPSCs [14]. One
simple explanation is that neither GluN2A nor GlutN2B are normally
expressed in these cells, thus leaving possible roles of other GluN2 (or
GluN3) subunits. Alternatively, because several subpopulations of hy-
pothalamic and extra-hypothalamic POMC neurons are known to exist,
including a hindbrain population [48e51], different cell groups may
functionally oppose each other with regard to body weight regulation.
Deletion from all POMC neurons will therefore result in an average
phenotype. It is also conceivable that long-term loss of either GluN2B
or GluN2A (or GluN1) is compensated during development by altered
neuronal circuits or genetic redundancy. Further studies are needed to
achieve understanding of this issue.
Figure 3: GluN2A in AgRP and POMC neurons is not required for normal body weight and energy intake. (A and C) Body weight (A) and cumulative food intake (C) (weeks
3e12) of control (GluN2Aﬂox/ﬂox) and AgRP-GluN2A KO female mice. (B and D) Body weight (B) and cumulative food intake (D) at week 12 of control (GluN2Aﬂox/ﬂox) and POMC-
GluN2A KO female mice. Data are shown as means  SEM (n ¼ 7/group). NS: Not signiﬁcant.
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Figure 4: Deletion of GluN2B in AgRP and POMC neurons: Pair-feeding and high-fat diet studies. (A) Body weight and cumulative food intake (weeks 3e9) of control
(GluN2Bﬂox/ﬂox) and AgRP-GluN2B KO female mice (n ¼ 4e6/group). (B) Body weight and cumulative food intake (weeks 4e10) of control (GluN2Bﬂox/ﬂox) and AgRP-GluN2B KO
male mice and control (GluN2Bﬂox/ﬂox) and POMC-GluN2B KO female mice during high-fat diet feeding. Data are shown as means  SEM (n ¼ 4e11/group). Repeated measures
two-way ANOVA or Student’s t test were conducted to evaluate differences between groups. NS: Not signiﬁcant.
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Figure 5: Deletion of GluN2B in AgRP and POMC neurons: Blood glucose and insulin, and glucose- and insulin-tolerance. (AeD) Fed blood glucose and insulin levels (15e
17 weeks of age) in animals from AgRP (A and C) and POMC (B and D) studies, respectively. (EeH) Glucose tolerance test (GTT) following 15 h food removal (2 mg/g D-glucose,
intraperitoneal) and insulin tolerance test (ITT) following 5 h food removal (1.2 U/kg insulin, intraperitoneal) (15e17 weeks of age) of AgRP (E and G) and POMC (F and H) studies,
respectively. AgRP and POMC data are from female and male mice, respectively, and are shown as means  SEM (n ¼ 3e9/group). P > 0.05 for all experiments applying
ANCOVA or repeated measures two-way ANCOVA. Logarithmic transformations were done for GTT values of AgRP study and ITT values of POMC study. Controls represent
GluN2Bﬂox/ﬂox mice. NS: Not signiﬁcant.
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It is established that hypothalamic AgRP neurons can inﬂuence feeding
behavior and body weight [1,3,4,52]. This is mediated in part by the
action of circulating factors including the fat-derived hormone leptin,
which informs these and other central nervous system (CNS) neurons
about whole body energy storage in the form of adipose tissue
[39,53,54]. We therefore investigated if the lean phenotype of GluN2B-
AgRP KO mice might be caused, at least in part, by altered leptin
action. We found that loss of GluN2B from AgRP neurons of leptin-
Figure 6: Elimination of GluN2B in AgRP neurons of Lepob/ob mice normalizes hyperglycemia independently body weight. (AeD) Body weight (A), body composition (8
weeks of age) (B), average daily food intake (week 7e8) (C), and blood glucose (D) in ob/ob controls (ob/ob;AgRP-ires-cre and ob/ob;GluN2Bﬂox/ﬂox) and ob/ob;AgRP-GluN2B KO
female mice. (E and F) Body weight (E) and food intake (F) of female mice (9 weeks of age) after implantation of osmotic pumps loaded with leptin (500 ng/h) (9 days). Values in E
and F are shown as percent of initial body weight and food intake, respectively. Data are shown as means  SEM (n ¼ 3e12 mice/group). Repeated measures two-way ANOVA or
Student’s t test were conducted to evaluate differences between groups. *P  0.05, **P  0.01. NS: Not signiﬁcant.
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deﬁcient Lepob/ob mice did not result in a reduction in body weight,
contrasting the data from Lepþ/þ;GluN2B-AgRP KO mice, suggesting
that leptin is required for this latter phenotype. To examine this further,
GluN2B-AgRP KO and control animals were given a high-fat diet (HFD)
which normally leads to leptin resistance in hypothalamic neurons,
accompanied by hyperphagia and accelerated weight gain [46,55,56].
Interestingly, GluN2B-AgRP KO mice exhibited the same caloric intake
and growth curve as control mice, therefore differing from the lower
Figure 7: Deletion of GluN2B from AgRP and POMC neurons: Neuron numbers (AeF) Representative microphotographs (hrGFP immunohistochemistry) and cell counts of
AgRP (A and C) and POMC (B and D) neurons in brain sections from body weight-matched (E and F) male control and KO animals (8 weeks of age). Data in Figure 8C and D are
presented as the mean neuron number  SEM (n ¼ 4e5 mice/group). Differences between groups were evaluated with Student’s t test. NS: Not signiﬁcant. ARC: Arcuate nucleus.
3V: Third ventricle. Images in (A) and (B) were captured at 20 magniﬁcation.
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body weight gain and hypophagia observed when KO animals were
provided a low-fat-chow diet. Thus, in two models of impaired leptin
action (Lepob/ob and diet-induced leptin resistance), the loss of GluN2B
in AgRP neurons does not appear to inﬂuence body weight balance,
altogether indicating that AgRP neurons normally serve as important
nodes integrating glutamate and leptin signals to regulate feeding and
body weight. Indeed, Lepob/ob mice lacking GluN2B only in AgRP
neurons had increased sensitivity towards the anti-obesity actions of
recombinant leptin suggesting that GluN2B-NMDARs normally antag-
onize leptin signaling within hypothalamic AgRP neurons. This is
consistent with the notion that leptin inhibits AgRP neuronal activity
[46], while glutamate typically increases neuronal activity.
These results raise several questions, including the nature of mech-
anisms explaining the lack of a lean phenotype of GluN2B-AgRP KO
mice when given a HFD. One possibility is that the HFD, directly (via
nutrients/factors in the diet) or indirectly (metabolites/hormones),
causes AgRP neurons to reach maximal neuronal activity (e.g. ﬁring)
driving orexigenic pathways forward, regardless of the (presumed)
lower baseline activity in GluN2B-AgRP KO mice due to reduced glu-
tamatergic input and/or increased leptin sensitivity. This possibility
could be tested with electrophysiological methods or by applying
DREADD (Designer Receptor Exclusively Activated by Designer Drugs)
technology. Alternatively, it is conceivable that the orexigenic capac-
ities of AgRP neurons are negated in states of diet-induced obesity,
either because of other neurons increasingly acting as the primary
drivers of feeding and body weight or because of changes in neuro-
circuitry/plasticity. Indeed, ablation of AgRP neurons in neonates can
be fully compensated, although to a lesser degree in adults [4,52].
In addition to its well described anti-obesity actions, leptin also has
potent beneﬁcial effects on blood glucose balance [9]. These anti-
diabetic effects in Type 2 diabetic animal models are mediated to a
large extent by inhibition of hypothalamic AgRP neurons and AgRP
neuropeptide release, presumably involving disinhibition of the
downstream melanocortin system [7,57]. Loss of glutamate action via
GluN2B containing NMDARs in AgRP neurons of wild-type mice did not
affect fed blood glucose levels, or insulin- or glucose-tolerance.
Interestingly however, deletion of GluN2B from AgRP neurons of the
severely diabetic and morbidly obese Lepob/ob mice completely pre-
vented development of hyperglycemia, independently of changes in
body weight and food intake. AgRP neurons in Lepob/ob mice are greatly
depolarized and exhibit increased ﬁring rates compared to lean mice
[58]. We therefore propose that GluN2B deletion from AgRP neurons of
Lepob/ob mice attenuates this hyperactivity and therefore reduces
neuropeptide (and neurotransmitter) release, including AgRP. This
would then allow for disinhibition of central melanocortin receptor
action, ultimately affecting blood glucose levels via a CNS-peripheral
pathway that is not yet fully understood [7]. GluN2B deletion thus
mimics the anti-diabetic effect of exogenous leptin acting on leptin
receptors expressed on AgRP neurons of Lepob/ob mice [7,9,59]. These
results bring forward the question of why loss of NR2B in AgRP
neurons only improves glucose homeostasis in Lepob/ob mice but is
without effect in lean mice. We speculate that the normal glucose level
present in control animals (per deﬁnition) is robustly defended by a
number of other systems and mechanisms, such that the presumed
reduction in AgRP neuronal activity caused by the loss of glutamate
action via NMDARs does not cause hypoglycemia. This hypothesis
Figure 8: Deletion of GluN2B from AgRP Neurons: Dendritic length. (A) Representative ﬂuorescence microphotograph (presented in grey tone) of dendrites of AgRP neurons in
AgRP-GluN2B KO and control (GluN2Bﬂox/ﬂox) male mice at 8 weeks of age. (B) Dendritic length of AgRP-GluN2B KO and control (GluN2Bﬂox/ﬂox) male in 8 week old mice. (C) Body
weight-matched groups of control and KO mice were pre-selected for these studies. Bar graph in Figure B shows the mean dendritic length  SEM (n ¼ 4e9 dendrites/group and
n ¼ 2e4 mice/group). *P  0.05, Student’s t test between neuron-speciﬁc GluN2B-deleted mice versus control mice (GluN2Bﬂox/ﬂox) at week 8. Scale bar in (A) represents 50 mm.
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could be explored by employing DREADD methodology; e.g. by
inhibiting/activating AgRP neurons in normoglycemic wild-type mice
and diabetic Lepob/ob mice.
NMDARs are expressed within or in close proximity to the post-
synaptic density of most excitatory synapses [17,18]. We have
recently reported that the leptin receptor, LepRb is also localized to
dendrites of hypothalamic POMC and AgRP neurons [60]. This sub-
cellular evidence, together with the in vivo metabolic results from the
current study, provides at least indirect support for possible cross-talk
between LepRbs and NMDARs in dendritic structures. Some evidence
is consistent with this notion. For example, leptin can modulate
NMDAR channel activity in isolated hippocampal neuronal cultures and
brain slices, requiring activation of phosphoinositide 3-kinase,
mitogen-activated protein kinase, and Src tyrosine kinase pathways
[61,62]. Furthermore, anti-depressant effects of leptin are reported to
involve NMDA receptor activity in hippocampal neurons [63,64]. In
addition, leptin can affect GluN2B-NMDA receptor-mediated Ca2þ
inﬂux in cerebellar granule cells via a mitogen-activated protein
kinase-dependent pathway [65]. To explain this cross-talk, one pos-
sibility worthy of consideration is Src-kinase dependent tyrosine
phosphorylation of the intracellular C-terminal domain of GluN2B,
which can affect NMDAR channel activity and synaptic surface-
localization [66,67]. Indeed, leptin receptors can activate Src family
members [68]. Future studies will be needed to elucidate the precise
signaling mechanism whereby this potentially critical dendritic cross-
talk between leptin receptors and NMDARs may occur.
In addition to mediating acute excitatory neurotransmission, NMDARs
are essential mediators of neuronal development, cell survival and
synaptic plasticity [21,34,35,69,70]. Indeed, GluN1 deletion from AgRP
neurons causes a decrease in dendritic spine number that is associ-
ated with an impaired response to fasting [14]. We show here that
genetic loss of GluN2B in AgRP neurons leads to a reduction in AgRP
cell number and in dendritic length. Although difﬁcult to prove directly,
it seems plausible that these structural changes following GluN2B
deletion contribute to the metabolic phenotypes observed here; e.g. the
attenuated number of orexigenic AgRP neurons may well explain the
reduced caloric intake and body weight of GluN2B-AgRP KO mice.
In conclusion, GluN2B expression in hypothalamic AgRP neurons is
required for normal control of caloric intake and body weight in lean
animals and can inﬂuence leptin sensitivity and glucose balance under
obese and diabetic conditions. GluN2B containing NMDARs may play a
role in AgRP neuronal survival and in excitability/connectivity via
changes in dendritic morphology. The latter could potentially provide a
mechanism explaining different body weight “set-points” in obesity.
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